능동형 이식형 의료기기 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of active implantable medical devices Market

The global active implantable medical devices market size was valued at USD 23.65 billion in 2025 and is projected to grow from USD 24.93 billion in 2026 to USD 39.44 billion by 2034, exhibiting a CAGR of 5.9% during the forecast period. North America dominated the global market with a 45.67% share in 2025, valued at USD 10.80 billion. Active implantable medical devices include pacemakers, implantable defibrillators, neurostimulators, cochlear implants, implantable drug delivery pumps, and other devices that use electrical or mechanical systems to improve patient health.

Market growth is supported by the increasing prevalence of cardiovascular and neurological disorders, hearing problems, an aging population, and technological advancements in implantable devices. Leading companies such as Medtronic, Abbott, Boston Scientific Corporation, Biotronik, and LivaNova are investing in product innovation, strategic collaborations, and regulatory approvals to expand their market presence.

MARKET DRIVERS

Rising Burden of Chronic Heart Conditions and Neurological Disorders

The increasing prevalence of cardiovascular and neurological conditions is driving demand for active implantable medical devices. Pacemakers, defibrillators, neurostimulators, and cochlear implants help patients manage chronic conditions and improve daily functioning. The aging population and increasing lifestyle-related diseases are expected to further support adoption.

MARKET RESTRAINTS

High Costs and Complex Surgical Requirements

High device costs, surgery expenses, hospitalization, imaging, and long-term follow-up can limit adoption, particularly in regions with limited insurance coverage. Complex surgical procedures and the need for specialized medical infrastructure can also restrict access to advanced implants.

MARKET OPPORTUNITIES

Growing Preference for Remote Monitoring and Connected Devices

Connected implants with wireless data transfer and remote monitoring capabilities are creating new growth opportunities. These technologies allow healthcare professionals to monitor device performance and patient health without frequent hospital visits. Abbott's Proclaim XR spinal cord stimulation system, approved in January 2023, included connectivity through its NeuroSphere Virtual Clinic.

ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET TRENDS

Growing Use of Smaller and Long-Lasting Implants

Manufacturers are increasingly developing smaller devices with longer battery life and improved electronics. Miniaturized pacemakers, neurostimulators, and implantable sensors can reduce patient discomfort and the need for repeat procedures. Better power management, wireless technologies, and efficient electronics are further supporting this trend.

MARKET CHALLENGES

Limited Patient Awareness and Fear of Implant Procedures

Limited awareness about the benefits of implantable devices and concerns regarding surgery, safety, long-term effects, and having a device inside the body can delay adoption. Education and improved patient communication remain important for increasing acceptance.

SEGMENTATION ANALYSIS

By Product Type

The market is segmented into cardiovascular implants, neuromodulation implants, hearing aids, implantable drug delivery pumps, and others. Cardiovascular implants held the largest share in 2025 due to widespread adoption of pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices. Neuromodulation implants are projected to grow at a 6.7% CAGR.

By Application

The application segments include cardiology, neurology, diabetes management, pain management, and others. Cardiology held the leading position in 2025 and is expected to account for 58.7% in 2026, supported by cardiovascular disease prevalence and an aging population. Neurology is projected to grow at a 6.6% CAGR.

By End User

Hospitals & clinics, homecare settings, and others form the end-user segments. Hospitals & clinics dominated the market and are projected to hold a 64.2% share in 2026, as most implant procedures require specialized surgical infrastructure. Homecare settings are projected to grow at a 6.0% CAGR.

ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REGIONAL OUTLOOK

North America

North America dominated with USD 10.80 billion in 2025. The U.S. market is projected to reach USD 9.73 billion in 2026, supported by advanced healthcare infrastructure, increasing chronic diseases, an aging population, and adoption of innovative implantable technologies.

Europe

Europe is projected to reach USD 6.95 billion in 2026, representing a 5.0% growth rate. The U.K., Germany, and France are expected to reach USD 1.13 billion, USD 1.56 billion, and USD 0.93 billion, respectively, in 2026.

Asia Pacific

Asia Pacific is projected to reach USD 4.53 billion in 2026, making it the third-largest regional market. China and India are estimated at USD 1.61 billion and USD 1.07 billion, respectively, in 2026.

Latin America and Middle East & Africa

Latin America is expected to reach USD 1.02 billion in 2026, while the GCC is projected to reach USD 0.27 billion. Increasing awareness, technological development, and improving healthcare infrastructure are supporting regional demand.

COMPETITIVE LANDSCAPE

Leading companies include Medtronic, Abbott, Boston Scientific Corporation, Biotronik, LivaNova PLC, Saluda Medical, NeuroPace, Cochlear Ltd., Infusyn Therapeutics, Blackrock Neurotech, BrainsWay, and Neuronetics. Companies are focusing on product launches, partnerships, acquisitions, collaborations, and regulatory approvals.

KEY INDUSTRY DEVELOPMENTS

In November 2025, Onward Medical received FDA home-use approval for its spinal cord stimulator. In April 2025, Abbott introduced an advanced platform designed to streamline electrode implantation. In March 2025, Newronika received CE IVD approval for its AlphaDBS system. In January 2025, Saluda Medical received FDA approval for its biomarker-based automated patient-programming platform. In October 2023, MicroPort Scientific launched ULYS ICD and INVICTA defibrillation leads in Japan.

REPORT COVERAGE

The report covers the global active implantable medical devices market size and forecast for 2025, 2026, and 2034, including market dynamics, drivers, restraints, opportunities, trends, challenges, segmentation by product type, application, and end user, regional analysis, competitive landscape, major companies, and key industry developments.

CONCLUSION

The global active implantable medical devices market is projected to grow from USD 23.65 billion in 2025 to USD 24.93 billion in 2026 and USD 39.44 billion by 2034, registering a 5.9% CAGR. Increasing cardiovascular and neurological disorders, an aging population, technological innovation, miniaturization, longer battery life, and connected remote-monitoring capabilities will continue to support market development. North America remains the leading regional market, while Europe and Asia Pacific are expected to provide significant opportunities through 2034.

Segmentation By Product Type, Application, End-user, and Region

By Product Type Cardiovascular Implants

• Cardiac Pacemakers
• Implantable Cardioverter Defibrillators
• Cardiac Resynchronization Therapy (CRT) Devices
• Others

Neuromodulation Implants

• Spinal Cord Stimulators
• Deep Brain Stimulators
• Vagus Nerve Stimulators
• Others
• Hearing Aids
• Implantable Drug Delivery Pumps
• Other

By Application

• Cardiology
• Neurology
• Diabetes Management
• Pain Management
• Others

By End-user

• Hospitals & Clinics
• Homecare Settings
• Others

By Region North America (By Product Type, Application, End-user, and Country)

• U.S. (By Product Type)
• Canada (By Product Type)

Europe (By Product Type, Application, End-user, and Country/Sub-region)

• Germany (By Product Type)
• U.K. (By Product Type)
• France (By Product Type)
• Spain (By Product Type)
• Italy (By Product Type)
• Scandinavia (By Product Type)
• Rest of Europe (By Product Type)

Asia Pacific (By Product Type, Application, End-user, and Country/Sub-region)

• China (By Product Type)
• Japan (By Product Type)
• India (By Product Type)
• Australia (By Product Type)
• Southeast Asia (By Product Type)
• Rest of Asia Pacific (By Product Type)

Latin America (By Size, Procedure, End-user, and Country/Sub-region)

• Brazil (By Product Type)
• Mexico (By Product Type)
• Rest of Latin America (By Product Type)

Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-region)

• GCC (By Product Type)
• South Africa (By Product Type)
• Rest of the Middle East & Africa (By Product Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2023/2024
• 4.2. Technological Advancements in Active Implantable Medical Devices
• 4.3. New Product Launches, Key Players
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Active Implantable Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Cardiovascular Implants
    • 5.1.1.1. Cardiac Pacemakers
    • 5.1.1.2. Implantable Cardioverter Defibrillators
    • 5.1.1.3. Cardiac Resynchronization Therapy (CRT) Devices
    • 5.1.1.4. Others
  • 5.1.2. Neuromodulation Implants
    • 5.1.2.1. Spinal Cord Stimulators
    • 5.1.2.2. Deep Brain Stimulators
    • 5.1.2.3. Vagus Nerve Stimulators
    • 5.1.2.4. Others
  • 5.1.3. Hearing Aids
  • 5.1.4. Implantable Drug Delivery Pumps
  • 5.1.5. Other
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Cardiology
  • 5.2.2. Neurology
  • 5.2.3. Diabetes Management
  • 5.2.4. Pain Management
  • 5.2.5. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals & Clinics
  • 5.3.2. Homecare Settings
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East and Africa

6. North America Active Implantable Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Cardiovascular Implants
    • 6.1.1.1. Cardiac Pacemakers
    • 6.1.1.2. Implantable Cardioverter Defibrillators
    • 6.1.1.3. Cardiac Resynchronization Therapy (CRT) Devices
    • 6.1.1.4. Others
  • 6.1.2. Neuromodulation Implants
    • 6.1.2.1. Spinal Cord Stimulators
    • 6.1.2.2. Deep Brain Stimulators
    • 6.1.2.3. Vagus Nerve Stimulators
    • 6.1.2.4. Others
  • 6.1.3. Hearing Aids
  • 6.1.4. Implantable Drug Delivery Pumps
  • 6.1.5. Other
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Cardiology
  • 6.2.2. Neurology
  • 6.2.3. Diabetes Management
  • 6.2.4. Pain Management
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals & Clinics
  • 6.3.2. Homecare Settings
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
    • 6.4.1.1. By Product Type
  • 6.4.2. Canada
    • 6.4.2.1. By Product Type

7. Europe Active Implantable Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Cardiovascular Implants
    • 7.1.1.1. Cardiac Pacemakers
    • 7.1.1.2. Implantable Cardioverter Defibrillators
    • 7.1.1.3. Cardiac Resynchronization Therapy (CRT) Devices
    • 7.1.1.4. Others
  • 7.1.2. Neuromodulation Implants
    • 7.1.2.1. Spinal Cord Stimulators
    • 7.1.2.2. Deep Brain Stimulators
    • 7.1.2.3. Vagus Nerve Stimulators
    • 7.1.2.4. Others
  • 7.1.3. Hearing Aids
  • 7.1.4. Implantable Drug Delivery Pumps
  • 7.1.5. Other
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Cardiology
  • 7.2.2. Neurology
  • 7.2.3. Diabetes Management
  • 7.2.4. Pain Management
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals & Clinics
  • 7.3.2. Homecare Settings
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.4.1. U.K.
    • 7.4.1.1. By Product Type
  • 7.4.2. Germany
    • 7.4.2.1. By Product Type
  • 7.4.3. France
    • 7.4.3.1. By Product Type
  • 7.4.4. Spain
    • 7.4.4.1. By Product Type
  • 7.4.5. Italy
    • 7.4.5.1. By Product Type
  • 7.4.6. Scandinavia
    • 7.4.6.1. By Product Type
  • 7.4.7. Rest of Europe
    • 7.4.7.1. By Product Type

8. Asia Pacific Active Implantable Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Cardiovascular Implants
    • 8.1.1.1. Cardiac Pacemakers
    • 8.1.1.2. Implantable Cardioverter Defibrillators
    • 8.1.1.3. Cardiac Resynchronization Therapy (CRT) Devices
    • 8.1.1.4. Others
  • 8.1.2. Neuromodulation Implants
    • 8.1.2.1. Spinal Cord Stimulators
    • 8.1.2.2. Deep Brain Stimulators
    • 8.1.2.3. Vagus Nerve Stimulators
    • 8.1.2.4. Others
  • 8.1.3. Hearing Aids
  • 8.1.4. Implantable Drug Delivery Pumps
  • 8.1.5. Other
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Cardiology
  • 8.2.2. Neurology
  • 8.2.3. Diabetes Management
  • 8.2.4. Pain Management
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals & Clinics
  • 8.3.2. Homecare Settings
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.4.1. Japan
    • 8.4.1.1. By Product Type
  • 8.4.2. Australia
    • 8.4.2.1. By Product Type
  • 8.4.3. China
    • 8.4.3.1. By Product Type
  • 8.4.4. India
    • 8.4.4.1. By Product Type
  • 8.4.5. Southeast Asia
    • 8.4.5.1. By Product Type
  • 8.4.6. Rest of Asia Pacific
    • 8.4.6.1. By Product Type

9. Latin America Active Implantable Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Cardiovascular Implants
    • 9.1.1.1. Cardiac Pacemakers
    • 9.1.1.2. Implantable Cardioverter Defibrillators
    • 9.1.1.3. Cardiac Resynchronization Therapy (CRT) Devices
    • 9.1.1.4. Others
  • 9.1.2. Neuromodulation Implants
    • 9.1.2.1. Spinal Cord Stimulators
    • 9.1.2.2. Deep Brain Stimulators
    • 9.1.2.3. Vagus Nerve Stimulators
    • 9.1.2.4. Others
  • 9.1.3. Hearing Aids
  • 9.1.4. Implantable Drug Delivery Pumps
  • 9.1.5. Other
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Cardiology
  • 9.2.2. Neurology
  • 9.2.3. Diabetes Management
  • 9.2.4. Pain Management
  • 9.2.5. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals & Clinics
  • 9.3.2. Homecare Settings
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.4.1. Brazil
    • 9.4.1.1. By Product Type
  • 9.4.2. Mexico
    • 9.4.2.1. By Product Type
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By Product Type

10. Middle East and Africa Active Implantable Medical Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Cardiovascular Implants
    • 10.1.1.1. Cardiac Pacemakers
    • 10.1.1.2. Implantable Cardioverter Defibrillators
    • 10.1.1.3. Cardiac Resynchronization Therapy (CRT) Devices
    • 10.1.1.4. Others
  • 10.1.2. Neuromodulation Implants
    • 10.1.2.1. Spinal Cord Stimulators
    • 10.1.2.2. Deep Brain Stimulators
    • 10.1.2.3. Vagus Nerve Stimulators
    • 10.1.2.4. Others
  • 10.1.3. Hearing Aids
  • 10.1.4. Implantable Drug Delivery Pumps
  • 10.1.5. Other
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Cardiology
  • 10.2.2. Neurology
  • 10.2.3. Diabetes Management
  • 10.2.4. Pain Management
  • 10.2.5. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals & Clinics
  • 10.3.2. Homecare Settings
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.4.1. South Africa
    • 10.4.1.1. By Product Type
  • 10.4.2. GCC
    • 10.4.2.1. By Product Type
  • 10.4.3. Rest of Middle East and Africa
    • 10.4.3.1. By Product Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles
  • 11.2.1. Abbott
  • 11.2.2. Boston Scientific Corporation
  • 11.2.3. Biotronik
  • 11.2.4. LivaNova PLC
  • 11.2.5. Saluda Medical
  • 11.2.6. NeuroPace
  • 11.2.7. Cochlear Ltd.
  • 11.2.8. Infusyn Therapeutics
  • 11.2.9. Blackrock Neurotech
  • 11.2.10. BrainsWay
  • 11.2.11. Neuronetics